INSTINCT
2017 Sepsis
? ICUs
100 patients
IVIg (25g/d for 3d) for necrotising STI - phys component summary at 180d. Unit protocol
Clinical Question
In patients with necrotising soft tissue infection (NSTI), does the use of
intravenous immunoglobulin (IVIG) compared to placebo improve patient
reported physical outcomes?
Critical Appraisal
Key findings
No sig diff.Mult issues (imbal orgms, HBOT, low dose IVIg, 1 dose pre enrol ok)
- Population
- Not recorded
- Population Details
- Not recorded
- Intervention Arms
- Not recorded
- Control Arms
- Not recorded
- Primary Outcome
- Not recorded
- Secondary Outcomes
- Not recorded
- P Value
- Not recorded
Outcome Results
Not recorded
Primary location: Denmark